Evidence map›Paper›PMID 25783606›Full record

ArticleInvestigative ophthalmology & visual science2015

Viral Vector Effects on Exoenzyme C3 Transferase-Mediated Actin Disruption and on Outflow Facility.

Sarah R Slauson, Donna M Peters, Marie K Schwinn, Paul L Kaufman, B'Ann T Gabelt, Curtis R Brandt

Open access · bronzeAbstract read
In one paragraph

Article in Investigative ophthalmology & visual science, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
1.2field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 12 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Review
  6. Lentiviral Vector-Mediated Expression of Exoenzyme C3 Transferase Lowers Intraocular Pressure in Monkeys.Molecular therapy : the journal of the American Society of Gene Therapy · 2019
    Article
  7. Article
  8. Article
  9. Review
  10. Cell Entry of C3 Exoenzyme from Clostridium botulinum.Current topics in microbiology and immunology
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Sarah R SlausonDepartment of Ophthalmology and Visual Sciences, University of Wisconsin, Madison, Wisconsin, United States.
Donna M PetersDepartment of Ophthalmology and Visual Sciences, University of Wisconsin, Madison, Wisconsin, United States 2Department of Pathology and Laboratory Medicine, University of Wisconsin, Madison, Wisconsin, United States 3McPherson Eye Research Institute, Uni.
Marie K SchwinnDepartment of Pathology and Laboratory Medicine, University of Wisconsin, Madison, Wisconsin, United States.
Paul L KaufmanDepartment of Ophthalmology and Visual Sciences, University of Wisconsin, Madison, Wisconsin, United States 3McPherson Eye Research Institute, University of Wisconsin, Madison, Wisconsin, United States.
B'Ann T GabeltDepartment of Ophthalmology and Visual Sciences, University of Wisconsin, Madison, Wisconsin, United States.
Curtis R BrandtDepartment of Ophthalmology and Visual Sciences, University of Wisconsin, Madison, Wisconsin, United States 3McPherson Eye Research Institute, University of Wisconsin, Madison, Wisconsin, United States.
University of Wisconsin–Madison · USSmith-Kettlewell Eye Research Institute · US

Funding

ZOLEDRONATE PREVENTS BONE LOSS IN OVARIECTOMIZED RHESUS MONKEYSP51RR000167 · NCRR · UNIVERSITY OF WISCONSIN-MADISON · PI WATKINS, DAVID I · 1985 to 2011
$106.7M
UW Vision Research Core - Administrative CoreP30EY016665 · NEI · UNIVERSITY OF WISCONSIN-MADISON · PI ROBERT W NICKELLS · 2005 to 2026
$12.6M
Control of Trabecular Meshwork CytoskeletonR01EY017006 · NEI · UNIVERSITY OF WISCONSIN-MADISON · PI PETERS, DONNA M · 2006 to 2024
$6.1M
Integrin Signaling in the Trabecular MeshworkR01EY020490 · NEI · UNIVERSITY OF WISCONSIN-MADISON · PI PETERS, DONNA M · 2010 to 2012
$1.1M
Tiam1/Rac1 effects on trabecular meshwork cytoskeletonF32EY018274 · NEI · UNIVERSITY OF WISCONSIN-MADISON · PI SCHWINN, MARIE · 2007 to 2009
$148k
NCRR NIH HHS P51 RR000167NEI NIH HHS EY0020490NEI NIH HHS EY017006NEI NIH HHS EY018274NEI NIH HHS F32 EY018274NEI NIH HHS P30 EY016665NEI NIH HHS R01 EY017006NEI NIH HHS R01 EY020490
6 · The paper itself

Abstract

purposePurified Clostridium botulinum exoenzyme C3 transferase (C3) effects on the actin cytoskeleton in human trabecular meshwork cells (HTM) and on the outflow facility response in monkey organ-cultured anterior segments (MOCAS) were determined in the presence or absence of viral vectors.

methodsHuman adenovirus type 5 (AdV) and feline immunodeficiency virus (FIV) vectors were produced using kits. Cell soluble purified C3 (C3cs) was purchased commercially. Recombinant C3 (C3rec) cDNA was overexpressed in Escherichia coli and purified. The HTM cells were incubated with up to 10 μg/mL C3cs or with 5 μg of C3rec and/or viral vector (multiplicity of infection [MOI] = 25). Cells then were fixed and stained for actin. Outflow facility in MOCAS was measured at baseline, 4 hours, 24 hours, and 3 to 4 days following bolus injection of AdV (1.6 × 107 transducing units) and/or 2.5 μg C3rec.

resultsThe HTM cells treated for 4 hours with C3cs (all doses) or for 24 hours with C3rec developed a rounded morphology and lost stress fibers. Cells transduced with vectors alone showed no changes at any time point. Cells exposed to C3rec and cotransduced with either viral vector showed significant disruption of the actin cytoskeleton within 4 hours after exposure, which persisted at 24 hours. In MOCAS, the AdV vector alone had no effect on outflow facility, but enhanced the response to C3rec at 4 hours.

conclusionsCoadministration of viral vectors enhances the ability of C3 transferase to disrupt actin stress fiber formation in HTM cells and increase outflow facility in MOCAS. Viral vectors potentially could be used to increase the bioavailability of proteins for cells that are difficult to transfect.

Indexed as

ActinsAdenoviruses, HumanAnimalsAqueous HumorCatsCells, CulturedComplement C3Disease Models, AnimalFollow-Up StudiesGenetic VectorsHaplorhiniHumansImmunodeficiency Virus, FelineOrgan Culture TechniquesTransferasesActinsComplement C3Transferases

Identifiers

PMID25783606
PMCPMC4408885
OpenAlexW2028067295

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.